Literature DB >> 1222316

[Significance of chemotherapy complementary to radiotherapy in stages I and II in Hodgkin's disease].

C Lagarde, J Chauvergne, M Durand, B Hoerni, G Hoerni-Simon, J Touchard.   

Abstract

In a series of 118 cases of Hodgkin's disease in stage I and II successively treated by irradiation alone or by chemotherapy followed by irradiation or by chemotherapy + irradiation + chemotherapy, a retrospective analysis brings out the share of classical radiotherapy in the cures associated with chemotherapy, which in providing a remission rate of the order of 90 p. 100 renders superfluous the maintenance of a long course of chemotherapy and of negligible interest the performance of an exploratory laparotomy.

Entities:  

Mesh:

Year:  1975        PMID: 1222316

Source DB:  PubMed          Journal:  Bull Cancer        ISSN: 0007-4551            Impact factor:   1.276


  1 in total

1.  Influence of dose intensity and density on therapeutic and toxic effects in Hodgkin's disease.

Authors:  P Lagarde; F Bonichon; H Eghbali; I de Mascarel; J Chauvergne; B Hoerni
Journal:  Br J Cancer       Date:  1989-04       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.